- £767.55m
- £765.63m
- £20.27m
Brief: Syncona Says Spur's FLT201 Demonstrates Favourable Safety & Tolerability Profile
Syncona Limited - Notice of Results
Brief: Syncona Says Purespring Therapeutics Raises 80 Mln Stg In Series B Financing
Brief: Syncona Says Resolution Therapeutics Raises 63.5 Mln Stg In Series B Financing
Syncona Limited - Directorate Change
Syncona Limited - First Quarter Update
Syncona Limited - Issue of Shares Pursuant to Incentive Scheme
Syncona Limited - Director Declaration
Syncona Limited - Notice of AGM
Brief: Syncona - Syncona Portfolio Company Beacon Therapeutics Raises $170 Million In A Series B Financing
Syncona Limited - Director/PDMR Shareholding
Syncona Limited - Director/PDMR Shareholding
Brief: Syncona Says Market Conditions Have Been Challenging
Brief: Syncona Adds Ionctura And Yellowstone Biosciences To Its Portfolio
Syncona Limited - Final Results
Brief: Syncona Limited - Quell Provides Clinical Updates On Qel-001
Syncona Limited - Notice of Results
Syncona Limited - Director Declaration
Syncona Limited - Acquisition of Freeline Becomes Effective